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Objective: to assess the representatlwty of small vascular samples w#h regard to the expresszon fsix zmportant factors 
~n atherosclerotzc vessels. 
Materials: czrcumferential frozen sections of dmc and femoral arterzes (n = 9)from patzents undergoing reconstructzve 
bypass urgery 
Methods: immunohzstochemistry with antzbo&es against macrophages (CD68), tumour necroszs factor alpha, t~ssue 
factor, t~ssue plasmmogen activator, urokznase plasmmogen actzvator and plasmmogen activator mhzbztor type 1. The 
distrzbutmn ofthese antzgens was character~sed by computer asszsted zmage analysis. Antigen pos~tzve area m randomly 
chosen samples of varying size was compared with antzgen posztwe area in the whole vessel transectzons 
Results: marked heterogenezty was found with respect to the expresszon f these factors in atherosclerotlc vessels. The 
representat~wty of samples was highly dependent on the szze of the samples. PAI-1 was more evenly expressed compared 
to the other antzgens 
Conclusions: estzmates of the expression of these factors based on small samples from atherosclerohc arterzes are 
unreliable. 
Key Words Atheroscleroszs; Immunohistochenustry, Heterogenezty, Representatzwty; Tumour Necroszs Factor Alpha; 
Tissue Factor; Tissue Plasmznogen Activator; Urokmase Plasmmogen Actzvator, Plasmmogen Activator Inlubztor 
Type 1. 
Introduction Tumour necrosis factor ~ (TNF~) stimulates pheno- 
typm changes in vascular smooth muscle cells and 
Research in human vascular biology is largely based endothelial cells) TF is the principal initiator of the 
on experimental studies performed on vascular speci- extrinsic pathway of coagulation. 6 Macrophages can 
mens obtained during surgical procedures. Con- produce these factors and increased numbers of in- 
clusions based on these studies depend on the flammatory cells seem to mcrease the risk of plaque 
representatlvity of the samples. While the structure of disruption and thrombosis. 7's
healthy vessels is uniform, atherosclerotic vessels are Tissue levels and localisatlon of these factors m vzvo 
more heterogeneous in their composition. An ath- can be explored by quantitative and morphological 
erosclerotic plaque consists of the necrotic core, the analysis of vascular specimens obtained from patxents 
fibrous capsule and the shoulder regions. Each of these undergoing surgical or endovascular p ocedures. Post- 
regions have a characteristic cellular composition. 1'2 mortem samples can also be used, but may be affected 
The molecular basis for development of ath- by several factors unrelated to the situation in vzvo. 
erosclerotic lesions and formation of arterial throm- The morphologic complexity and heterogeneous struc- 
bosis is not fully understood. Some of the key ture of vessels with advanced atherosclerosls render 
compounds are proteolytic enzymes, cytokines and interpretation of results difficult with small size 
tissue factor (TF). Plasmin degrades fibrin and regu- samples. 
lates the activation of matrix metalloproteinases. "4 The present study characterlsed the representatxvlty 
of vascular biopsies with a hmited size with regard to 
* Please address all correspondence to M Falkenberg, Department 
of Vascular Surgery, Bruna str~ket 11, room 440, Sahlgrenska Urn- the expression of macrophages (using the anti-CD68 
verslty Hospital, Ostra, 413 45 Gothenburg, Sweden. antibody), TNF~, TF, tissue plasminogen activator 
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(t-PA), urokmase plasminogen activator (u-PA) and 
plasminogen activator inhibitor type 1 (PAI-1) in CD68 ",~- ~ '  u-PA :, 
human atherosclerotic vessels ~ ,~!  ~ '~ "~ £ d y, 
Materials and Methods 
Circumferential biopsms (n=9) of femoral and iliac TNF TF ,,'~'~ S~ "*, 
arteries were taken from pahents undergoing re- f ~ :-y} 
constructive vascular procedures for atherosclerotic ,~  . ':: ~ \ - -  .~"- { i~ . .  ._ 7._.. *
occlusive disease. Vascular segments excluded from ~b ~ , G f f  
the circulation during bypass operations were used. '~  -~ " ' ~ - ~ ~ J J  
The specimens contained all vessel ayers, including 
the adventitia. The study was approved by the local , ~. ~ .  =~,  
t - rA  /" ~,~ ~:~ ~,~ PAI - I  ~.,~2~. ethics committee and the patients gave informed con- j - ' ,~ ~ ---t-.,, a~ ~, . : ,~  -v%-,~ 
sent. The biopsies were snap frozen in liquid nitrogen , /  ,~e-~,~ ~ 
and stored in -70 °C until cryostat sectioning. ~*~'~ d"  2, ,' /9 t [  ~ '~ 
hnmunohistochemzstry. Frozen sections of 6 gm were 
immunostained formacrophages (CD68), TNF~, TF, t . . . . . . .  5 mm 
PA, u-PA and PAI-1 using the APAAP technique. 9 The 
cryostat sections were thawed in room temperature of Fig. 1. Computerlsed images of serial sections from an fllac artery. 
20°C and fixed in acetone. Sections were incubated for Regions with poslhve immunostammg, as judged m the mmroscope, 
are marked m black The uneven dmtribution f the anhgens i  
i h with mouse monoclonal primary antibodies. The demonstrated Macrophage poslhve regions (CD68) m the mhma 
sections were then incubated with rabbit anti-mouse and the medm were usually also posltwe for the other antigens TF 
IgG (Z 412, Dako, Glostrup, Denmark, diluted 1:40) and t-PA were expressed m the adventltla and the vasa vasorum 
PAI-1 had the most wMespread dmtnbuhon 
for 30 min. Primary and secondary antibodies were 
diluted m PBS with 5% bovine serum albumin. Ten Aspergillus niger glucose oxMase (X931, Dako, Glo- 
per cent of human serum was added to the secondary strup, Denmark). 
antibody. After 30 mm incubation with APAAP com- 
plexes (alkaline phosphatase and mouse monoclonal Computer assisted image analyszs, A method for visu- 
anti-alkalme phosphate complexes, D 651, Dako, Glo- alismg antigen distribution on circumferential cross- 
strup, Denmark, diluted 1:40 in TBS), the sections were sections of atherosclerotic arteries was developed 
washed with TBS before adding alkaline phosphatase (Falkenberg et aI., Cardiovascular Pathology, in press). 
substrate for 30 min. Finally, the sections were coun- Photocopies on white paper were made of photo- 
terstained w~th haematoxylin and mounted in poly- micrographs of the sections. These photocopies were 
wnyl alcohol (pH 7.4). used to mark regions with positive staining for the 
antigens The immunostained sechons were examined 
Primary antibodies. All primary antibodies were mouse m high magnificahon. Staining was judged as either 
monoclonal IgG1. Optimal dilution of each anhbody positive or negative. No semiquantitative assessment 
was determined for minimal non-specific staining with based on staining intensity was made. Regions with 
maximal sensitiwty. Anti TNF~ (no. %1549) was pur- positive staining were identified and marked on the 
chased from Sigma, St Louis, U.S.A. and diluted 1:80 photocopies manually with a marker pen. On a sep- 
Anti TF (#4509) was acquired from American Dia- arate photocopy the boundary of the cross-section was 
gnoshca, Greenwich, U.K. and diluted 1:10. Anti t-PA marked, creating a mask image of the vessel. The 
(PAM 3), anti u-PA (MUK 1) and anti PAI-1 (MAI- resulting diagrams were imported into a computerised 
11) were purchased from Biopol, UmeA, Sweden and image analysis ystem (KS400, Carl Zelss, Oberkocken, 
diluted 1:10, 1:20 and 1:40 respectively. For macro- Germany) by a CCD camera. The antigen diagrams 
phage detection monoclonal mouse antl-CD68 anti- and the mask diagrams were merged in the computer. 
body (no. M718) from Dako, Glostrup, Denmark, Resulting images howed the area of the vessel tran- 
diluted 1:60, was used. The negative control was iso- section and regions with positwe staining for each 
tope-matched mouse monoclonal anhbodies against antigen (Fig. 1). The proportion of antigen positive 
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The square root SD(X) of the expected value represents 
. . . . . . . .  ~ , ,i~ "~ : the standard eviation of the difference between the 
i proportion of positive area in a randomly selected 
: i ' ~ rectangle and the corresponding quantity of the whole 
, ~ picture. The larger the standard eviation is, the less ~,[~ ~ I i! ~/ /~iii ;li:~ i~j~ I ,, accuratetheest imatebasedonarectang le l so f the  
proportion of positive area in the whole vessel. The 
.... !i I ~llk~/i lli i /~ ~:~: pr°cedure was the same f°ra l ls lzes  ° f r e c t a n g l e s ' ' ~ , ~  
When studying S.D (x) as a function of x a second 
, order regression function was used. Because of the 
~ ,~ ~ ~ [ ,  i i~ i~!~'~,  i evident restrictlons s.D.(0)=0 and s.D (1)=0 (if no or 
all of the tissue area is positive then any sample 
~ will give a perfect estimate) the general second order 
......... ~ i i~  =~/i ~ regressi°n m°del S'D'(X) = C0 + el(x-- C2X2) Was reduced 
to S .D . (X)=b(x -x2) ,  where b is a constant. Thus, the 
inchnation of the function S.D.(X) depended on the 
Fig. 2. Computensed image of a vessel transection with antigen value of the constant b. The constant b for a certain 
positive regions marked. Theproportion of antigen positive tissue 
m the section was measured A 6 x 6 grid divided the image m 36 size (2 x 2, 3 x 3, etc) and a cer ta in  antigen was de- 
rectangles and each rectangle was measured By combmmg adlacent termined by regression analysis (the least square sum 
rectangles(2x2,3x3,4x4and3x6)  samples of varymg slze could method). By use of S.D.(X) the probability can be ap- 
be analysed and compared to the whole transection. 
proximately calculated that the estimated proportion 
of positive tissue will deviate more than a certain 
area on each section was calculated. The marking of amount from x when a size of 2 x 2, 3 x 3, 4 x 4 or 3 x 6 
positive regions on photocopies was made by one of rectangles i used. 
the investigators in all sections. Ten sections were 
independently examined by another investigator and 
the correlation coefficient with respect to antigen- Results 
positive area between the investigators was 0.98, con- 
firming the reliability of procedure. CD68 + macrophages (Fig. 3a) were located mainly in 
To study the distribution of antigens a 6 x 6 grid the shoulders, the fibrous cap and the necrotic core of
was applied on the computerised image and each plaques. Scattered cells were found in the adventitia 
of the 36 squares that was obtained was analysed and in mural thrombi. CD68 staining was more intense 
separately (Fig. 2). To examine amaximum number of compared to the other antigens. TNFcz was also positive 
possible alternative biopsies, six consecutive analyses in plaques, following the pattern of CD68 (Fig. 3b). A 
were carried out for each arterial section, with the grid diffuse staining was also found in the adventitla of 
rotated 7° between analyses. To mimic tissue biopsies some specimens. Tissue factor was positive in the 
of relevant and different size, the final analysis was adventitia nd in plaques (Fig. 4a). t-PA was positive 
not done on the 36 generated squares eparately, but in endothelial cells of the adventitia, in the vasa va- 
adjacent squares were added to generate larger "biops- sorum and in macrophage rich regions of the lesions 
ies" of the size 2 x 2, 3 x 3, 4 x 4 and 3 x 6 rectangles. (Fig. 5a). PAI-1 had the most wide spread expression 
Two times two rectangles represented 11% (4/36), 3 x 3 (Fig. 1), being positive in both plaques and in vessel 
rectangles represented 25%, 4 x 4 rectangles rep- structures without macroscopic signs of atherosclerotic 
resented 44% and 3 x 6 rectangles represented 50% of lesions (Fig. 5b), u-PA was positive in areas with 
the whole image, which included the complete section clusters of macrophages (Fig. 5d). Control sections 
of the vessel. For each "biopsy" the amount of tissue were negative (Figs 2b, 5c). 
area and the amount of positive area was determined The mean proportion of antigen positive area in 
vascular transections was highest for PAI-1; 0.143, Stat~stzcal methods. The proportion x of positive area (range 0.012-0.450), followed by TF1; 0.091 (0.061- 
in the whole image was determined and also the 0.149), CD68; 0 059 (0.014-0.094), TNF~; 0.051 (0.008- 
expected value of the square of the difference between 0.098) and t-PA; 0.047 (0.016-0.086). The smallest area 
x and the proportion of positive area of each rectangle, of antigen expression was found for u-PA; 0.023 (0.005- 
The expected value was calculated by adding all 0.059) (Table 1). 
squared ifferences of the rectangles of a certain size Analysis of the rectangular areas ("biopsies") cre- 
and dividing the sum by the number of such rectangles, ated through image analysis howed that the accuracy 
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Fig. 3. (a) Stenotlc Ihac artery lmmunostamed for the macrophage marker CD68 On the top of the picture is the lumen Positive staining 
appears m red colour The uneven &stnbutlon of macrophages is illustrated (b) AdJacent section showing posltlve staining for tumour 
necrosis factor c< (TNF~) m macrophage rich regions and a diffuse staining m the adventltm 
, . :2.~'~: .~  ,~ . . ' = ~ ::.,..: ' i ~ ' ~ ' ' .~ ~<:HL  °'~ '~  
i i J 
Fig. 4. (a) Plaque w~th positive staining for bssue factor (red colour) (b) Control section ~s negabve. 
(d} 
Fig. 5. Sections of atherosclerobc femoral artery ]mmunostamed for (a) tissue plasmmogen activator (t-PA), (b) plasmmogen activator 
inhibitor type I (PAI-1) (c) control antibodies and (d) urokmase plasmmogen activator (u-PA) Positive staining appears m red colour 
of estimating the expressxon of these antigens in a The standard eviation of the difference between 
vessel by analysis of a randomly selected sample is rectangles of the size of 2 x 2, 3 x 3, 4 x 4, 3 x 6 andthe 
highly dependent on the size of the sample whole vessel cross section is illustrated in Fig. 6a,b for 
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(a) Proportzon of CD68 posmve area (b) Proportion of PAL1 positive area 
Fig. 6. Diagrams demonstrating the representatlvlty of samples of different sizes with respect to the expression of (a) macrophages (CD68) 
and (b) PAI-1 The computensed image of the vessel transection was divided into 36 rectangles (6 x 6) Four different sizes of samples 
were analysed, 2x 2 rectangles (correspondmg to 11% of the vessel transection), 3 x 3 rectangles (25%), 4 x 4 rectangles (44%) and 3 x 6 
rectangles (50%) On the y-axis is the standard ewatmn of the differences between multiple samples and on the x-axis m the proportion 
of antigen positive tissue area m the whole sectmns It is clear that the variability of anhgen expression m highly dependent on the size 
of the samples PAI-1 + area was more widespread (mean 0 143, range 0 012-0.450) compared to CD68 + area (mean 0059, range 0 014-0 094) 
and therefore the scales of the two dmgrams are not the same The curves were calculated by a second order egression functlon, s D (X) = 
b(x-x2), where x m the proportion of positive area m the whole sections, and b is a constant determined for each size and each antigen, 
see stattsttcal methods Mean, range and values of the constant b for all examined antigens and sample sizes are hsted m Table 1 
CD68 and PAI-1. The standard deviat ion was cal- samples with smaller size were analysed The lmport-  
culated by  the funct ion S.D.(x) =b(x -x  2) where x is ance of the sample size is demonstrated in Fig. 7. The 
the proport ion of ant igen posit ive area in the whole 95% confidence interval  of CD68 and PAI-1 posit ive 
cross-section and  b is a determined constant for each areas in samples was marked ly  decreased if the sample 
ant igen and each sample size (see Statistical methods), size was doub led  from 25% (3 x 3 rectangles) to 50% 
The values of the constant b for all ant igens are l isted (3 x 6 rectangles) of the vessel transection. 
in Table 1. 
PAI-1 had the lowest values of the constant b, which 
is consistent with the fact that PAI-1 was found both 
m plaques and  in unaffected parts of the vessels. The Discussion 
other ant igens had higher values of b and accordingly 
higher s tandard eviat ion between samples, reflecting The present s tudy explored the distr ibut ion of macro- 
the focal accumulat ion of these factors in plaques, phages, TNF~, TF, t-PA, u-PA and PA]-I in cir- 
Samples taken outs ide these areas had little or no cumferent ia l  vascular sections from pat ients ubjected 
expression of CD68, TNF~, TF, t-PA or u-PA, whi le to reconstruct ive surgery due to occlusive ath- 
samples taken from the p laque shoulder  or the necrotic erosclerotic disease. We found that the representat iv i ty 
core had very h igh proport ions of posit ive area for all of samples wi th  respect to the expression of these 
the invest igated antigens, factors was h ighly dependent  on the size of the 
The s tandard ev iat ion was highly increased when samples. This demonstrates  that the d istr ibut ion of 
Table 1. Mean values and ranges of tissue area positive for macrophages (CD68}, tumour necrosis factor alpha (TNF~), tissue factor 
(TF), tissue plasminogen activator (t-PA}, urokinase plasminogen activator (n-PA) and plasminogen activator inhibitor type 1 (PAI-1). 
The constant b determines the standard eviation of samples as a function of antigen expression i the whole section (see Statistical 
methods) and is listed for each antigen and for four different sizes of samples; 2 x 3, 3 x 3, 4 x 4 and 3 x 6 rectangles, ee comments in 
the text. 
Antigen CD68 TNF~ TF t-PA u-PA PAI-1 
Mean 0 059 0 051 0 091 0 047 0 023 0 143 
Range 0 014-0 094 0.008-0 98 0.061-0 149 0 016-0 086 0 005-0 059 0 012-0 450 
b. 2 x 2 1 15 1 08 0 83 0 98 1 03 0 62 
b 3x3 073 069 058 060 062 043 
b 4x4 041 046 039 039 038 030 
b 3x6 022 0.33 031 037 039 010 
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CD68 3 x 3 /CD68 3 x 6 the adventltia. Increased expression of TF antigen 
0 12 - 0 12 ~ and achvity has been demonstrated in atherosclerotic 
~ / plaques.6,13 5 TF is recognised as the principal initiator 
/ 
0 08 0 08 ~ / of coagulation 16 and local increase in plaques can be 
0 04 0.04 ~- / important for fibrin formation and thrombotic om- 
b /  plications. 
~,'1 I I r The plasmin system is essential in thrombolysis 
0 04 0 08 0.04 0.08 and hssue remodelling. 17 t-PA is the most important 
PAI-1 3 x 3 PAI-1 3 x 6 plasminogen activator in circulating blood, while u- 
PA appears to regulate cellular proteolysis and de- 0.12 I 0.12 
I gradahon of the extracellular matrix. 18 These  activators 
0 0 8 /  008f  / are controlled by plasminogen activator inhibitors. 
Increased levels of t-PA, u-PA and PAI-1 have been 
0 04 0 04 ~/  found in atherosclerotic vessels compared to healthy 
~,'1 I I controlsJ 9'2° In the present study PAI-1 was more 
0 04 0 08 0.04 o.08 evenly distributed than both t-PA and u-PA, suggesting 
Fig. 7. Diagram illustrating fine effect of mcreasmg the sample size that plasminogen activation in the vessel wall may be 
from 25% (3 x 3 rectangles) to 50% (3 x 6 rectangles) of the vessel regulated by focal increase of activators while in- 
transechon On the y-axm are the proporhons ofantigen positive hibitors arrest the fibrinolytic cascade in the sur- 
areas m samples and on the x-axis are the actual proporhons mfine rounding tissue. 
whole sechons The grey area represents the 95% confidence interval 
By doubhng the raze of samples, the accuracy ofestimating the The heterogeneity of atherosclerotic plaques with 
expression f CD68 (macrophages) and PAI-1 m the vessel is mark- respect to cellular composition was observed 10 years 
edly improved The representahvlty of samples concerning the ago with immunohistochemistry 1,2 The concept of 
expression fPAI-1 is better than regarding the CD68 + area 
heterogeneity as an indicator of atherosclerotic plaque 
quality is thoroughly explored in the field of ultra- 
these factors is heterogeneous in atherosclerotic ves- sonography. Carotid lesions with heterogeneous ultra- 
sels. PAI-1 had a more widespread expression and sound characteristics have been associated with 
was more evenly distributed compared to the other 
factors Detection of immunohistochemical st ining on increased risk of neurological symptomsY The cellular 
and molecular background to this is not established. 
tissue sections requires high magnification and only 
small areas can be evaluated at a time in the micro- Increased numbers of macrophages in carotid plaques 
scopic setup. In this study images of antigen expression with mural thrombi 1° and the heterogeneous dis- 
in whole vessel transections were created by manual tribution of macrophages in atherosclerotic arteries 
marking of positive regions on photocopies. Positive support the concept that inflammatory activity in 
area in random samples of varying size was compared plaques may promote thromboembolic complications. 
to positive area m the whole vessel transection, to The anatomical distribution of atherosclerotic le- 
calculate the representativity as a function of sample sions m humans uggests that local factors uch as i.e. 
size. turbulent blood flow, low shear stress and vessel wall 
Macrophages and other inflammatory cells are vir- hypoxia influence atherosclerotic development. 22-z4 At 
tually absent in healthy arteries but are abundant in bypass surgery vascular specimens can be obtained 
atherosclerotic plaques. Macrophages eem to in- from the anastomotic sites. However, the location of 
fluence the stabihty and thrombogenicity of the lesions the anastomosis is often chosen because of its relative 
absence of sclerosis, and may not be representative and large numbers of macrophages have been as- 
sociated with plaque rupture and thrombosis in cor- for the patient's disease. In fact, the first report of 
onary and carotid arteries. 7'8'1°. Macrophages are increased PAI-1 mRNA in atherosclerosis arteries com- 
principally located in the necrotic ore, in the fibrous pared normal appearing aorhc samples obtained from 
cap and m the shoulder egions of plaquesJ "2Tumour the site of the proximal anastomosis with severely 
from the same pahents. necrosis factor ~ is an inflammatory mediator prin- atherosclerotic aortic samples • 25
cipally produced by activated macrophages. TNF~ is The situation is even more uncertain when very small 
found in atherosclerotic plaques and can be involved atherectomy specimens, obtained uring endolummal 
in neovessel formation and hemorrhagic necrosis in catheter procedures, are used for morphological or 
the lesions,  TNF~ also stimulates phenotypic changes quantitative studies. J ohnson  26 reported on the hetero- 
m smooth muscle cells and endothelial cells, lu2 Tissue geneous morphology of peripheral atherectomy speci- 
factor m healthy vessels is predominantly located in mens. In one study the content of TF in 63 atherectomy 
Eur J Vasc Endovasc Surg Vol 16, October 1998 
282 M. Falkenberg et al. 
spec imens ranged f rom 0-47 rig/g.27 Fur thermore ,  tis- The role of plasmmogen activators mthe regulatzon of connective 
tissue metalloprotemases Ann NY Acad Scz 1992; 667 1-12 
sue levels of substances appear ing  in c lusters may 5 BARATH P, FISHBEIN M, CAO J, BERENSON J, HELFANT R, 
be confounding.  A molecu le  may be found in equal  FORREST~R J Detection and locahsation of tumor necrosm 
concentrat ions in d iseased and  normal  vessels,  yet  it factor m human atheroma Am J Ca~&ol 1990; 65 297-302 
may be crucial  for the pathophys io logy ,  due to local 6 WiLcox JN, SMIT].I KM, SCHWARTZ SM, GORDON D Locahsatlon 
of tzssue factor m the normal vessel wall and m the atherosclerotzc 
increase in crit ical parts  of the lesions, plaque Proc Natl Acad Scz USA 1989, 86 2839-2843 
When vascu lar  spec imens of l imi ted size are used 7 VAN DER WAL AC, BECKER AE, VAN DER LOGS CM, DAS PK Szte 
in scientif ic s tu&es,  the var iab i l i ty  due  to the hetero-  of mtlmal rupture or erosion of thrombosed coronary athero- 
sclerotic plaques IS characterized by an inflammatory process 
geneous structure of atherosclerot ic  vessels can be irrespective of the dommant plaque morphology Czw,laflon 
compensated  for by  increas ing the number  of speci-  1994, 89 3644 
mens.  Consider ,  for example ,  the propor t ion  of macro-  8 MORENO PR, FALK E, PALACIOS IE NEWELL JB, FUSTER V, FALLON 
JT Macrophage infiltration m acute coronary syndromes Im- 
phage pos i t ive area (Fig 6a, Fig 7). If samples  of 25% pllcatlons for plaque rupture Ctrculatmn 1994, 90 775-778 
of the vessel  t ransect ion (3 x 3 rectangles in our  model )  9 CORDELL JL, FALINI B, ERBER WN, GHOSH AK, ABDULAZIS Z, 
are used instead of 50% (3 x 6 rectangles)  the s tandard  MAcDoNALD S, PULFORD KAF, STEIN H, MASON DY Im- 
munoenzymatlc labehng of monoclonal antlbo&es using lm- 
dev ia t ion  wi l l  increase f rom 0 .22(x -x  2) to 0.73(x-xa), mune complexes of alkahne phosphatase and monoclonal nti- 
where  x is the true propor t ion  of the CD68 pos i t ive  alkahne phosphatase (APAAP complexes) J H~stochem Cytochem 
1984; 32 219-229 
area. The increase is 3.3 t imes. In order  to compensate  10 MILEI J, PARODI JC, FERNANDEZ-ALONSO G, BARONE A, 
for that, the size of the s tudy  has to be increased by  BEIGELMAN R, FERREIRA LM, ARRIGONI G, MATTURRI L. Carotid 
the square of 3.3, i.e. it has to be 10.9 t imes as large, atherosclerosls tmmunocytochemlcal analysm of the vascular 
Since no good serum marker  of card iovascu lar  d isease and cellular composition m endarterectomles Ca~dmlogza 1996, 
41 535-542 
is avai lable,  the prospect  of t issue analys is  on vascu lar  11 LI H, FREEMAN MW, LIBBY P Regulation of smooth muscle cell 
samples  f rom pat ients,  for d iagnost ic  and prognost ic  scavenger receptor expression m wvo by atherogemc &ets and 
m vitro by cytokmes J Chn Invest 1995, 95 122-133 
use, seems attractive. Unfortunate ly ,  such an analys is  12 SCHLEET RR, BEVILACQUA MP, SAWDEY M, GIMBRONE MA, Lo- 
may not  be successful  due to the heterogeneous  struc- SKUTOFF DJ Cytokme actlvatzon of vascular endothehum J Bml 
ture of atherosclerot ic  vessels. In the cl inical s i tuat ion Chem 1988, 263 5797-5803, 
it is usua l ly  not  poss ib le  to compensate  the poor  13 THIRUVIKRAMANSV, GuHAA, RoBOZJ, TAUBMANMB, NEI',IERSON 
representat iv i ty  of samples  by  increas ing the numbers ,  Y, FALLON JT In sztu locahsatlon of tissue factor m human 
atherosclerotlc p aques by bmdmg of &goxlgenm-labeled factors 
and  the pred ic t ive  va lue of samples  w i th  a l imi ted VIIa and X Lab Invest 1996, 75-451461 
size wi l l  be low. 14 KATO K, ELSAYED YA, NAIvIOTO M, NAGAGAWA K, SUEISHI K 
In summary ,  analys is  of t issue samples  f rom pat ients  Enhanced expression oftissue factor actlwty m the atherosclerotlc 
aortas of cholesterol-fed rabbits Thromb Res 1996; 82 335-347 
with atherosclerot ic  d isease is an essential  component  15 TAUBMAN MB, FALLON J% SCHECTER AD, GIESEN P, MENDLOWITZ 
of vascu lar  b io logy  research. However ,  the results  M, FYTE BS, MARMUR JD, NEMERSON Y Tissue factor m the 
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